GENE ONLINE|News &
Opinion
Blog

CAR-T Cell
Kite Pharma Licences Teneobio’s Antibody Platform to Fight Multiple Myeloma
2020-04-03
Daiichi Sankyo Seeks Yescarta Approval in Japan for Relapsed or Refractory B-cell Lymphoma
2020-04-01
Green Cross Cell Seeks FDA approval for CAR-T therapy against pancreatic cancer
2020-03-27
Using the Power of Multiplex Genome Engineering to Treat Cancer
2020-02-12
M&A
Astellas Procures Xyphos Biosciences as Second Acquisition in December
2019-12-31
R&D
Gene Editing Companies to Exchange Patented Tech to Develop Cancer Therapies
2019-10-28
BioJapan 2019 Kicks Off with Importances on New Bioeconomy Strategy
2019-10-10
Weekly in Asia 2019|AUG-2
2019-08-03
Weekly in Asia 20190609-0615
2019-06-21
Asian Biotechnology Conference BIO ASIA to be held in Taiwan for the first time
2019-01-15
M&A
Targeted cancer radiopharma specialist – ENDOCYTE INC.’s acquisition
2018-10-23
Tracking “OFF THE SHELF” CAR-T Cell therapy & an IPO worth $100M
2018-10-15
Cambridge startup, GO Therapeutics make $195 million deal with Roche
2018-10-05
Ceasefire update on CRISPR’s USA patent battle
2018-09-17
Fighting Lung Cancer with Precision Warfare
2018-06-21
1 2 3
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top